João Gama-Marques is an expert in Psychiatry at Hospital Júlio de Matos (Portugal). As of October 2026, ScienceLeadR ranks João Gama-Marques in the top 1% of experts in Portugal for Schizophrenia Spectrum and Other Psychotic Disorders and Psychotic Disorders. João Gama-Marques has authored 146 publications, the most recent in 2026. SLR score: 532 (community average: 125). How the SLR is computed.

LeadR Profile

João Gama-Marques Hospital Júlio de Matos Portugal
532 ScienceLeadR Reputation 532
Network Map

Psychiatry

Subspecialties: Pharmacy - Neurology - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

João Gama-Marques (MD, MSc, PhD) graduated from medical school at Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal (2006), where he has also been teaching psychiatry for more than ten years (2009). He finished his residency in adult psychiatry at Hospital Júlio de Matos, Centro Hospitalar Psiquiátrico de Lisboa, Lisboa, Portugal (2013), where he develops his clinical and research work.

João Gama-Marques was awarded with the European Federation of Psychiatric Trainees’ scholarship in London, England, United Kingdom (2012); the Japanese Society of Psychiatry and Neurology’s fellowship in Tokyo, Japan (2016); and the European College of Neuropsychopharmacology’s scholarship in Oxford, England, United Kingdom (2016).

João Gama-Marques received his Psychopharmacology Masters (MSc) from the Neuroscience Educational Institute in Carlsbad, California, United States of America (2018); and completed his Neuroscience Doctorate (PhD) at Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal (2020).

João Gama-Marques has been working in Hospital da Luz, Lisboa, Portugal since 2013 and achieved the position of graduate consultant psychiatrist at Hospital Júlio de Matos, Unidade Local de Saúde São José, Lisboa, Portugal, since 2024.

João Gama-Marques' main interests are focused in clinical and research work with homeless people living and dying in Lisboa, Portugal, affected by primary (idiopathic) and secondary (organic) psychosis, from schizophrenia and schizoaffective disorders spectra.

Organizations

Career arc: 2008 - 2026

Source: PubMed

Hospita de Júlio de Matos

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 146

Citations

Citations: 1 019 1st author: 43 Last author: 25 Unique author: 39


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Recommendations for quality care indicators in severe asthma multidisciplinary units in Portugal (PRECISION project): A nationwide consensus.
PMID 42536117 — respiratory tract diseases, therapeutics, asthma
Pulmonology20260
Effects of n-3 PUFA supplementation during resistance training on muscle outcomes in healthy adult men: A randomized clinical trial.
PMID 42415329 — muscles, fatty acids, omega-3, hypertrophy, resistance training, tissues, fatty acids
Br J Nutr20260
The interictal psychoses of epilepsy: A systematic review of case reports.
PMID 42217159 — epilepsy, signs and symptoms, seizures, therapeutics, psychotic disorders
Epileptic Disord20260
Underprescription of Clozapine: A Narrative Review Regarding 'Clozaphobia'.
PMID 42136059 — caregivers, schizophrenia, psychopharmacology, records, clozapine, therapeutics
Hum Psychopharmacol20260
Feasibility and safety of parallel Shockwave® balloon percutaneous mitral valvuloplasty for degenerative mitral stenosis.
PMID 41966262 — constriction, pathologic, mortality, safety, cardiology, morbidity, therapeutics, mitral valve stenosis, balloon valvuloplasty, lithotripsy
Rev Port Cardiol20260

LeadR Networks

Main global connection map